Saturday on W5: experts warn the next pandemic could come sooner than you think, and that unless changes are made to industrial farming practices worldwide, it could spark a virus more deadly than COVID-19.
๐๐๐ ๐๐ฃ๐ ๐๐ก๐ฉ๐ง๐๐จ๐ค๐ช๐ฃ๐ ๐พ๐๐ฃ ๐๐ฃ๐๐๐ ๐พ๐๐ฃ๐๐๐ง ๐ฟ๐ง๐ช๐๐จ ๐๐ฃ๐ฉ๐ค ๐ฉ๐๐ ๐ฝ๐ง๐๐๐ฃ ๐๐๐จ๐๐๐ง๐๐๐๐ง๐จ ๐๐๐ซ๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐๐ ๐ ๐ฉ๐๐๐๐ฃ๐๐ฆ๐ช๐ ๐ฉ๐ค ๐๐๐ฉ ๐ฉ๐ง๐๐๐ฉ๐ข๐๐ฃ๐ฉ๐จ ๐ฉ๐๐ง๐ค๐ช๐๐ ๐ฉ๐๐ ๐ฅ๐ง๐ค๐ฉ๐๐๐ฉ๐๐ซ๐ ๐๐ก๐ค๐ค๐-๐๐ง๐๐๐ฃ ๐๐๐ง๐ง๐๐๐ง
๐๐ง ๐ ๐ง๐๐ฐ ๐ฌ๐ญ๐ฎ๐๐ฒ, ๐ซ๐๐ฌ๐๐๐ซ๐๐ก๐๐ซ๐ฌ t๐๐ฆ๐ฉ๐จ๐ซ๐๐ซ๐ข๐ฅ๐ฒ ๐ฆ๐๐๐ ๐ญ๐ก๐ ๐๐ฅ๐จ๐จ๐-๐๐ซ๐๐ข๐ง ๐ฆ๐จ๐ซ๐ ๐ฉ๐๐ซ๐ฆ๐๐๐๐ฅ๐, ๐๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ ๐ฆ๐จ๐ง๐จ๐๐ฅ๐จ๐ง๐๐ฅ ๐๐ง๐ญ๐ข๐๐จ๐๐ฒ ๐ญ๐จ ๐ญ๐๐ซ๐ ๐๐ญ ๐๐๐ง๐๐๐ซ ๐ญ๐ก๐๐ญ ๐ก๐๐ ๐ฌ๐ฉ๐ซ๐๐๐ ๐ญ๐จ ๐ญ๐ก๐ ๐๐ซ๐๐ข๐ง.
A new way to usher treatments through the protective blood-brain barrier.
This videoclip is an excerpt of a movie produced by CGTN America entitled โGene Therapies and the Promise of the Fountain of Youthโ which was released in January 2021.
He aรฑadido S/T en Espaรฑol.
Los Angeles-based NovaSignal Inc. recently launched the second version of their artificial intelligence (AI)-a guided robotic platform for assessing cerebral blood flow in order to guide real-time diagnosis. The platform uses ultrasound to autonomously capture blood flow data, which then gets sent to their HIPAA-compliant cloud system so that clinicians can access the exam data from anywhere on their personal devices.
Founded in 2,013 the company states they have raised overโฆ See more.
Los Angeles based NovaSignal Inc. recently launched a second version of their artificial intelligence (AI)-guided robotic platform for assessing cerebral blood flow in order to guide real-time diagnosis. The platform uses ultrasound to autonomously capture blood flow data, which then gets sent to their HIPAA-compliant cloud system so that clinicians can access the exam data from anywhere on their personal devices.
Founded in 2,013 the company states they have raised over $25 million in federal research funding and hold 18 patents. They also have over 130 peer-reviewed citations to their work. NovaSignalโs products are FDA-cleared in the United States, CE-marked in Europe, and licensed in Canada.
A โperfect stormโ of several crises, such as climate change and the Covid-19 pandemic, mean many nations are โknocking on famineโs door,โ Beasley said.
A small group of ultra-wealthy individuals could help solve world hunger with just a fraction of their net worth, says the director of the United Nationsโ World Food Programme.
Billionaires need to โstep up now, on a one-time basisโ, said David Beasley in an interview on CNNโs Connect the World with Becky Anderson that aired Tuesday โ citing specifically the worldโs two richest men, Jeff Bezos and Elon Musk.
โ$6 billion to help 42 million people that are literally going to die if we donโt reach them. Itโs not complicated,โ he added.
๐
As someone who rides, reviews, and covers news on electric motorcycles, I hear the same thing all the time: โIโd love an electric motorcycle, but theyโre all so expensive. Maybe when prices come down.โ
And I get it. Electric motorcycles really are expensive. Zeroโs flagship electric motorcycles cost $20,000. LiveWires are a couple thousand more. And Energicas are a couple thousand more than that. But somehow a little-known, highway-capable electric motorcycle popped up in North America for just US $5,990, and it seems like no one noticed. Iโm talking about the Kollter ES1 electric motorcycle.
Weโve been discussing a potential impending influx of affordable electric motorcycles from Asia for several years now. However, the COVID-19 pandemic created a significant delay in the rollout of several of those anticipated Asian models.
An international team of researchers wants to find people who are genetically resistant to SARS-CoV-2, in the hope of developing new drugs and treatments.
Imagine being born naturally resistant to SARS-CoV-2, and never having to worry about contracting COVID-19 or spreading the virus. If you have this superpower, researchers want to meet you, to enrol you in their study.
As described in a paper in Nature Immunology1 this month, an international team of scientists has launched a global hunt for people who are genetically resistant to infection with the pandemic virus. The team hopes that identifying the genes protecting these individuals could lead to the development of virus-blocking drugs that not only protect people from COVID-19, but also prevent them from passing on the infection.
โItโs a terrific idea,โ says Mary Carrington, an immunogeneticist at the Frederick National Laboratory for Cancer Research in Bethesda, Maryland. โReally, a wise thing to do.โ
Like weather forecasting, disease forecasting needs to be statistical.
While we cannot predict in advance exactly how many hurricanes will occur this year or how bad they will be, we know with great confidence that climate change is a risk factor increasing the frequency and severity of hurricanes. Our knowledge of this and all the other risk factors for hurricanes allows us to make a statistical prediction for the coming season.
Similarly, we have known for decades that therโฆ See more.
Iโve written before about the need for infectious disease intelligence and whether or not we can insure against damages from future outbreaks. Both ideas assume that epidemics can, to some extent, be predicted. But can they?
The lack of control and idiosyncrasies of the current Covid-19 pandemic (like multiple โwavesโ of transmission), might cause some to wonder if predicting epidemics is a lost cause. A comparison of the performance of 27 individual models made by many of the best academic scientists showed high high variability in forecast skill across time, geospatial units, and forecast horizons. Only just more than half of the models evaluated showed better accuracy than simply assuming the number of cases per week will stay the same for the next 4 weeks.
There is no cure for the disease, for which Alzheimerโs is the most common form (about 75% of dementia cases).
But finding out what raises the risk can help people try and prevent it.
A new study has offered more clues about the type of people who typically get Alzheimerโs.
The COVID-19 pandemic, caused by SARS-CoV-2, continues to rage in many countries, straining health systems and economies. Vaccines protect against severe disease and death and are considered central to ending the pandemic. COVID-19 vaccines (and SARS-CoV-2 infection) elicit antibodies that are directed against the viral spike (S) protein and neutralize the virus. However, the emergence of SARS-CoV-2 variants with S protein mutations that confer resistance to neutralization might compromise vaccine efficacy[1]. Furthermore, emerging viral variants with enhanced transmissibility, likely due to altered virus-host cell interactions, might rapidly spread globally. Therefore, it is important to investigate whether emerging SARS-CoV-2 variants exhibit altered host cell interactions and resistance against antibody-mediated neutralization.